2-(2-呋喃基)嘧啶 | 27110-82-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2-(2-呋喃基)嘧啶
• 英文名称: 2-(furan-2-yl)pyrimidine
• 英文别名: 2-(2-furyl)pyrimidine；2-furan-2-yl-pyrimidine；(2-Furyl)-pyrimidin
• CAS: 27110-82-3
• 化学式: C₈H₆N₂O
• 分子量: 146.148
• InChiKey: LKQWUJWBYVAURT-UHFFFAOYSA-N

物化性质

• 熔点：
  67-69 °C
• 沸点：
  154.5±22.0 °C(Predicted)
• 密度：
  1.179±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  38.9
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(2-呋喃基)嘧啶 生成 2-(5-nitro-furan-2-yl)-pyrimidine
  参考文献：
  名称：

  Pankiewicz,J. et al., Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1975, vol. 281, p. 39 - 41

  摘要：

  DOI：
• 作为产物：
  描述：

  2-(Furan-2-yl)-1,4,5,6-tetrahydropyrimidine 在 吡啶 、 sodium hydroxide 作用下， 以 二氯甲烷 、 二甲基亚砜 为溶剂， 反应 3.0h， 生成 2-(2-呋喃基)嘧啶
  参考文献：
  名称：

  Efficient and Benign One-Pot Conversion of N-Tosyl-1,4,5,6-tetrahydropyrimidines to Pyrimidines via Tandem β-Elimination and Aromatization

  摘要：

  An efficient, mild, benign, and practical method for one-pot conversion of N-tosyl-1,4,5,6-tetrahydropyrimidines into pyrimidines is discussed in detail. In this method, N-tosyl-1,4,5,6-tetrahydropyrimidines are first prepared via N-tosylation of tetrahydropyrimidines with TsCl and then treated with 1.5 equivalents of NaOH in dimethylsulfoxide (DMSO) under air at 60 degrees C to afford corresponding pyrimidines in 70-95% yields via cascade -elimination and aromatization. [Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) for the following free supplemental resources: Full experimental and spectral details.]

  DOI：

  10.1080/00397911.2013.764433

文献信息

• [EN] INHIBITORS OF INFLUENZA VIRUS REPLICATION AND USES THEREOF<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS DE LA GRIPPE ET UTILISATIONS ASSOCIÉES
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018108125A1

  公开（公告）日：2018-06-21

  The invention provides a class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

  本发明提供了一类作为流感病毒复制抑制剂的化合物、其制备方法、含有这些化合物的药物组合物，以及这些化合物和药物组合物在治疗流感中的用途。
• Palladium(0)-Catalyzed, Copper(I)-Mediated Coupling of Cyclic Thioamides with Alkenylboronic Acids, Organostannanes, and Siloxanes
  作者：Nuzhat Arshad、Jamshed Hashim、C. Oliver Kappe

  DOI：10.1021/jo900848s

  日期：2009.7.17

  The Pd-catalyzed cross-coupling of cyclic thioamides and thioureas with alkenylboronic acids, vinyl- and (het)arylstannanes, and arylsiloxanes in the presence of stoichiometric amounts of a Cu(I) cofactor is described. The desulfitative C−C cross-coupling protocol of the Liebeskind−Srogl type is performed under neutral conditions and can be applied to a range of heterocyclic structures with embedded

  描述了在化学计量的Cu（I）辅因子存在下，Pd催化的环硫酰胺和硫脲与烯基硼酸，乙烯基和（杂）芳基锡烷以及芳基硅氧烷的交叉偶联。Liebeskind-Srogl类型的脱硫C-C交叉偶联方案是在中性条件下进行的，可应用于具有嵌入的硫酰胺片段的杂环结构。通过使用单模反应器或多模并联反应平台在100°C下进行受控的微波辐射，交叉偶联通常可在1-3 h内完成，并以良好的收率进行。
• [EN] INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF<br/>[FR] INHIBITEURS DE RÉPLICATION DU VIRUS DE LA GRIPPE, PROCÉDÉS D'APPLICATION ET UTILISATIONS ASSOCIÉES
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2018033082A1

  公开（公告）日：2018-02-22

  A class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

  一类化合物作为流感病毒复制抑制剂，其制备方法，含有这些化合物的药物组合物，以及这些化合物和药物组合物在治疗流感中的用途。
• [EN] CF3O-containing enaminoketones and their utilization for the preparation of CF3O-containing pyrazoles<br/>[FR] ÉNAMINOCÉTONES CONTENANT CF3O ET LEUR UTILISATION POUR LA PRÉPARATION DE PYRAZOLES CONTENANT CF3O
  申请人：BAYER IP GMBH

  公开号：WO2013120876A1

  公开（公告）日：2013-08-22

  The present invention pertains to novel enaminoketones containing a CF3O-group, novel pyrazole-derivatives containing a CF3O group as well as to a novel process for their preparation comprising aminoformylation of CF30-ketones and cyclization of the obtained CF30-enaminoketones with hydrazines to trifluoromethoxy pyrazoles.

  这项发明涉及含有CF3O基团的新型烯胺酮，含有CF3O基团的新型吡唑衍生物，以及一种新型制备它们的方法，包括CF30-酮的氨基甲酰化和所得的CF30-烯胺酮与肼环化生成三氟甲氧基吡唑。
• CF3O-containing enaminoketones and their utilization for the preparation of CF3O-containing pyrazoles
  申请人：Bayer CropScience AG

  公开号：EP2628722A1

  公开（公告）日：2013-08-21

  The present invention pertains to novel enaminoketones containing a CF3O-group, novel pyrazole-derivatives containing a CF3O group as well as to a novel process for their preparation comprising aminoformylation of CF3O-ketones and cyclization of the obtained CF3O-enaminoketones with hydrazines to trifluoromethoxy pyrazoles.

  这项发明涉及含有CF3O基团的新型烯胺酮，含有CF3O基团的新型吡唑衍生物，以及一种新型制备它们的方法，包括CF3O酮的氨基甲酰化和所得CF3O烯胺酮与肼的环化反应，形成三氟甲氧基吡唑。